INTRODUCTION
Routine meningococcal vaccination campaigns have substantially reduced the burden of invasive meningococcal disease in pediatric individuals, leading to relative increases in burden in older age groups. There is a need for safe, effective meningococcal vaccines that can be used across broad age ranges. Men...
Olga Syrkina, M. Bausch-Jurken, Arlette Delgado et al.· Expert Review of Vaccines· 0 citations
Invasive meningococcal disease (IMD), caused by Neisseria meningitidis, remains a rare but devastating condition characterized by rapid clinical progression, high case fatality, and long-term morbidity. Despite effective conjugate (or alternative) vaccine availability, sporadic cases and outbreaks persist across the ag...
M. Bausch-Jurken, Sean Leng, Jana Shaw et al.· Infectious Disease and Thera...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.